MARKET

SXTPW

SXTPW

60 Degrees Pharm
NASDAQ
0.0263
-0.0086
-24.64%
Closed 09:30 11/10 EST
OPEN
0.0263
PREV CLOSE
0.0263
HIGH
0.0263
LOW
0.0263
VOLUME
2.91K
TURNOVER
0
52 WEEK HIGH
0.1499
52 WEEK LOW
0.0211
MARKET CAP
--
P/E (TTM)
-0.0042
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SXTPW last week (1102-1106)?
Weekly Report · 2d ago
Weekly Report: what happened at SXTPW last week (1026-1030)?
Weekly Report · 11/02 09:35
60 Degrees Pharmaceutical Enters Sponsored Research Agreement With University Of Southern Mississippi To Assess The Potential Of Castanospermine In Nonclinical Models Of Alpha-Gal Syndrome
Benzinga · 10/28 12:32
Weekly Report: what happened at SXTPW last week (1019-1023)?
Weekly Report · 10/26 09:34
Weekly Report: what happened at SXTPW last week (1012-1016)?
Weekly Report · 10/19 09:34
Weekly Report: what happened at SXTPW last week (1005-1009)?
Weekly Report · 10/12 09:37
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Barchart · 10/06 07:10
Weekly Report: what happened at SXTPW last week (0928-1002)?
Weekly Report · 10/05 09:36
More
About SXTPW
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.

Webull offers 60 Degrees Pharmaceuticals Inc stock information, including NASDAQ: SXTPW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SXTPW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SXTPW stock methods without spending real money on the virtual paper trading platform.